Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia - PubMed (original) (raw)
Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia
Eugene Trogan et al. Arterioscler Thromb Vasc Biol. 2004 Sep.
Abstract
Objective: We determined the effects of sustained normocholesterolemia on advanced mouse atherosclerosis and whether changes in plaque size and composition can be detected noninvasively by MRI.
Methods and results: Aortic arch segments containing advanced lesions from apolipoprotein E-deficient (apoE-/-) mice (total cholesterol 1281+/-97 mg/dL) were transplanted into syngeneic wild-type (WT; 111+/-11 mg/dL) or apoE-/- (702+/-74 mg/dL) recipient mice on chow diet. Mice underwent serial MRI at 3, 5, 7, and 9 weeks after transplantation. Compared with 3 weeks, correction of dyslipidemia in WT recipient mice resulted in a monotonic decrease (regression) in arterial wall volume, whereas in apoE-/- recipient mice, further plaque progression was noted (P<0.05). MRI and histological measurements were closely correlated (R=0.937). The lesional content of macrophages decreased >90% (P<0.001), and smooth muscle cells increased in the WT recipient mice. In vivo T(1)-, T(2)-, and proton density-weighted images of the mouse thoracic aorta differentiated intraplaque lipid and collagen.
Conclusions: Plaque changes can be noninvasively monitored by serial in vivo MRI of a mouse regression model. Our ability to image the thoracic aorta and perform in vivo plaque characterization will further enhance atherosclerosis studies. Serial in vivo MRI of mouse arterial plaque after correction of dyslipidemia revealed a monotonic decrease in lesion size (regression) and changes in lesion composition consistent with a stable plaque phenotype. Serial in vivo MRI will enhance studies of plaque regression in animal models in response to therapeutic interventions.
Similar articles
- Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL, Loeb SM, Weisgraber KH. Raffai RL, et al. Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):436-41. doi: 10.1161/01.ATV.0000152613.83243.12. Epub 2004 Dec 9. Arterioscler Thromb Vasc Biol. 2005. PMID: 15591220 - Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH. Oumouna-Benachour K, et al. Circulation. 2007 May 8;115(18):2442-50. doi: 10.1161/CIRCULATIONAHA.106.668756. Epub 2007 Apr 16. Circulation. 2007. PMID: 17438151 - [Value of in vivo monitoring of abdominal aortic atherosclerosis by high field magnetic resonance imaging in apoE-/- mice fed a high fat diet or infused with angiotensin II].
ZHAO R, YAO YY, DENG G, JU SH, WANG ZJ, WEN S, CHEN J, JIN H. ZHAO R, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Sep;38(9):823-8. Zhonghua Xin Xue Guan Bing Za Zhi. 2010. PMID: 21092653 Chinese. - A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice.
Coleman R, Hayek T, Keidar S, Aviram M. Coleman R, et al. Acta Histochem. 2006;108(6):415-24. doi: 10.1016/j.acthis.2006.07.002. Epub 2006 Sep 26. Acta Histochem. 2006. PMID: 17007910 Review. - Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress.
Meir KS, Leitersdorf E. Meir KS, et al. Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1006-14. doi: 10.1161/01.ATV.0000128849.12617.f4. Epub 2004 Apr 15. Arterioscler Thromb Vasc Biol. 2004. PMID: 15087308 Review.
Cited by
- Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages.
Feig JE, Shang Y, Rotllan N, Vengrenyuk Y, Wu C, Shamir R, Torra IP, Fernandez-Hernando C, Fisher EA, Garabedian MJ. Feig JE, et al. PLoS One. 2011;6(12):e28534. doi: 10.1371/journal.pone.0028534. Epub 2011 Dec 6. PLoS One. 2011. PMID: 22163030 Free PMC article. - Quantification of plaque lipids in the aortic root of ApoE-deficient mice by 3D DIXON magnetic resonance imaging in an ex vivo model.
Dietel B, Budinsky L, Kuehn C, Uder M, Achenbach S, Hess A. Dietel B, et al. Eur Radiol. 2015 Mar;25(3):736-44. doi: 10.1007/s00330-014-3456-7. Epub 2014 Oct 31. Eur Radiol. 2015. PMID: 25358593 - Role of LpL (Lipoprotein Lipase) in Macrophage Polarization In Vitro and In Vivo.
Chang HR, Josefs T, Scerbo D, Gumaste N, Hu Y, Huggins LA, Barrett TJ, Chiang SS, Grossman J, Bagdasarov S, Fisher EA, Goldberg IJ. Chang HR, et al. Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):1967-1985. doi: 10.1161/ATVBAHA.119.312389. Epub 2019 Aug 22. Arterioscler Thromb Vasc Biol. 2019. PMID: 31434492 Free PMC article. - Effects of Pharmacological Thermogenic Adipocyte Activation on Metabolism and Atherosclerotic Plaque Regression.
Worthmann A, Schlein C, Berbée JFP, Rensen PCN, Heeren J, Bartelt A. Worthmann A, et al. Nutrients. 2019 Feb 23;11(2):463. doi: 10.3390/nu11020463. Nutrients. 2019. PMID: 30813320 Free PMC article. - Syndecan-1 modulates the motility and resolution responses of macrophages.
Angsana J, Chen J, Smith S, Xiao J, Wen J, Liu L, Haller CA, Chaikof EL. Angsana J, et al. Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):332-40. doi: 10.1161/ATVBAHA.114.304720. Epub 2014 Dec 30. Arterioscler Thromb Vasc Biol. 2015. PMID: 25550207 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous